UBC Hodgkin Lymphoma Subtypes Study | Cancer Discovery Findings
UBC and BC Cancer researchers uncover four biologically distinct subtypes of classic Hodgkin lymphoma, enabling precision medicine for better patient outcomes in Canada.
No reviews yet. Be the first to rate Christian!
Dr. Christian Steidl is a Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia. He serves as Research Director of the Centre for Lymphoid Cancer at BC Cancer and Executive Director of Research at BC Cancer Research Centre. He holds an MD from the University of Münster, Germany, and a PhD-equivalent degree from the University of Witten-Herdecke, Germany. His translational research group focuses on the pathogenesis of B-cell lymphomas, tumor microenvironment biology, and applied genomics. Dr. Steidl contributed to the discovery of novel somatic gene mutations in B-cell lymphomas using next-generation sequencing and established microenvironment composition, including tumor-associated macrophages and normal B cells, as novel biomarkers for outcome prediction in Hodgkin lymphoma. These studies have resulted in high-impact publications with him as first or senior author in journals including the New England Journal of Medicine, Nature, Nature Genetics, Cancer Discovery, the Journal of Clinical Oncology, and Blood.
Dr. Steidl leads major research initiatives, including a CIHR Foundation grant on cellular crosstalk in lymphoma, a Terry Fox Research Institute team grant on treatment failure in lymphoid cancers, and a Genome Canada Large-Scale Applied Research Project on personalized treatments for lymphoid cancer patients. He has received the Allen Distinguished Investigators Award from the Paul Allen Frontiers Group and was inducted as a member of the Royal Society of Canada, College for New Scholars, Artists and Scientists in 2017. He serves on the Scientific Advisory Board of the Lymphoma Research Foundation, as past Chair of the American Society of Hematology Scientific Committee on Lymphoid Neoplasia, and as a member of the Leukemia and Lymphoma Society of Canada Medical and Scientific Advisory Committee. His work promotes precision oncology through collaborations with scientific consortia and clinical trials groups.
Professional Email: null
UBC and BC Cancer researchers uncover four biologically distinct subtypes of classic Hodgkin lymphoma, enabling precision medicine for better patient outcomes in Canada.